G 蛋白抑制剂 YM-254890 是一种全性
Tony Trent1, Justin J Miller1, Gregory R Bowman1
1Department of Biochemistry, Biophysics, and Chemical Biology, University of Pennsylvania, Philadelphia, PA, 19104-6059.
自然产品YM-254890 (YM) 通过稳定其构造,特别抑制Gq/11G蛋白. 了解这种机制可能会导致新的G蛋白特异性药物.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- G蛋白结合受体 (GPCR) 是主要的药物标.
- 准G蛋白,GPCRs的作用因子,提供了治疗潜力.
- YM-254890 (YM) 选择性地抑制Gq/11G蛋白,显示出有前途的结果.
研究的目的:
- 调查YM特异性的机制.
- 了解G蛋白的结构动力学如何影响抑制剂结合.
- 促进新型,特定的G蛋白抑制剂的开发.
主要方法:
- 从分子动力学模拟中构建了马尔科夫状态模型 (MSM).
- 模拟的Gα子单元和异构三基G蛋白 (Gα-Gβγ).
- 分析了形状分布和全oster合.
主要成果:
- 对YM敏感的Gα蛋白显示出更高的YM结合的类似形状.
- 在Gα上的YM和Gβγ结合位之间存在强大的全结合.
- Gβγ 结合增强了 YM 结合 (正合作性) 的 Gα 预组织.
结论:
- 黄作为一种"全性",稳定了Gα-Gβγ复合体.
- G 蛋白质构成组合决定了抑制剂的特异性.
- 这项研究为设计特定的针对G蛋白的药物提供了框架.
更多相关视频
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
相关概念视频
Activation and Inactivation of G Proteins
G-protein Coupled Receptors
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Allosteric Regulation
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
